Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context

Affiliations

• ¹ College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, A1910, PHR 3.208J, Austin, TX, 78712, USA. claire.zagorski@austin.utexas.edu.
• ² HIV Prevention Research Division, Department of Psychiatry, School of Medicine, University of Pennsylvania, 3535 Market Street, Suite 4000, Philadelphia, PA, 19104, USA.
• ³ Narcomedia, Inc., Philadelphia, PA, USA.
• ⁴ National Survivors Union, 1116 Grove St, Greensboro, NC, 27403, USA.
• ⁵ Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, 135 Dauer Drive, Chapel Hill, NC, 27599, USA.
• ⁶ University of Pennsylvania School of Nursing, Fagin Hall, 418 Curie Blvd, Philadelphia, PA, 19104, USA.
• ⁷ Greater Lawrence Family Health Center, 34 Haverhill Street, Lawrence, MA, 01841, USA.
• ⁸ College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, A1910, PHR 3.208J, Austin, TX, 78712, USA.
• ⁹ Department of Pharmacology, Bowles Center for Alcohol Studies, University of North Carolina, CB#7178, 104 Manning Road, Chapel Hill, NC, 2759, USA.
• ¹⁰ University of North Carolina, 725 MLK Jr. Blvd., CB 7505, Chapel Hill, NC, 27599, USA.